{"id":45198,"date":"2021-02-18T09:40:17","date_gmt":"2021-02-18T14:40:17","guid":{"rendered":"https:\/\/dev.inrs.ca\/?p=45198"},"modified":"2021-02-18T09:51:00","modified_gmt":"2021-02-18T14:51:00","slug":"improving-stroke-treatment-with-a-modified-therapeutic-molecule","status":"publish","type":"post","link":"https:\/\/dev.inrs.ca\/en\/news\/improving-stroke-treatment-with-a-modified-therapeutic-molecule\/","title":{"rendered":"Improving stroke treatment with a modified therapeutic molecule"},"content":{"rendered":"\n

A research team from the Institut national de la recherche scientifique (INRS) has improved the protective effect of a molecule against ischemic stroke, which is caused by an interruption of blood flow to the brain.<\/strong><\/p>\n\n\n\n

\"\"
Ischemic stroke are caused by an interruption of blood flow to the brain.<\/figcaption><\/figure><\/div>\n\n\n\n

Every year in Quebec, about 20,000 people have a stroke. Also known as a \u201ccerebral infarction\u201d, this sudden neurological deficit can lead to psychological and physical after-effects. These effects result from an increase in glutamate in the brain, which destroys neurons. \u201cGlutamate is an essential neurotransmitter for neuronal communication, learning and memory processes, yet above a certain concentration, it becomes toxic to neuronal cells,\u201d explains Ahlem Zaghmi, a newly graduated INRS doctoral student under the supervision of Professor Marc A. Gauthier<\/a>.<\/p>\n\n\n\n

The research team aimed at developing an effective treatment that would compensate for the increase in glutamate, in collaboration with a Spanish team. What makes its approach unique? It works on the periphery. <\/p>\n\n\n\n

\u201cUnlike other drugs, our molecule does not need to cross the blood-brain barrier to achieve its therapeutic effect. It represents one fewer obstacle, since it could be injected intravenously.\u201d<\/p>Ahlem Zaghmi, a graduate student<\/cite><\/blockquote>\n\n\n\n

The modified molecule, glutamate-oxaloacetate transaminase (GOT), is already known for its therapeutic effects. This enzyme breaks down the glutamate circulating in the bloodstream which creates a kind of siphon effect. \u201cBy decreasing concentrations of this neurotransmitter in the blood, excess glutamate in the brain will move out to compensate for the loss. This \u201csiphons\u201d the glutamate out of the brain,\u201d she says.<\/p>\n\n\n\n

Long-lasting efficiency<\/strong><\/h2>\n\n\n\n

A single dose of the molecule typically lasts three hours in rats. Due to the modification made by the research team, the treatment is now effective for six days! \u201cAdding a polymer, polyethylene glycol, on the surface of the GOT enzyme increases its circulation time in the blood. The polymer will, among other things, protect the molecule from the immune system,\u201d says Professor Gauthier, a specialist in bioorganic chemistry and biomaterials. \u201cThis has the advantage of maintaining the siphon effect over a period of time that exceeds the duration of the glutamate peak caused by the stroke in the brain, while reducing the number of doses given and the risk of side effects,\u201d adds Ahlem Zaghmi.<\/p>\n\n\n\n

The research team now intends to observe the longer-term effect of the molecule and explore applications to other neuronal diseases. Since glutamate toxicity is also associated with head trauma, Parkinson’s and Alzheimer’s disease, the research group could, among other things, test whether the modified molecule accelerates healing or, if so, slows the development of the disease.<\/p>\n\n\n\n

About the study<\/strong><\/h3>\n\n\n\n

The article \u201cSustained blood glutamate scavenging enhances protection in ischemic stroke<\/a>\u201d, by Ahlem Zaghmi, Antonio Dopico-L\u00f3pez, Mar\u00eda P\u00e9rez-Mato, Ram\u00f3n Iglesias-Rey, Pablo Hervella, Andrea A. Greschner, Ana Bugallo-Casal, Andr\u00e9s da Silva, Mar\u00eda Guti\u00e9rrez-Fern\u00e1ndez, Jos\u00e9 Castillo, Francisco Campos P\u00e9rez, and Marc A. Gauthier, was published in the Communications Biology<\/a> of Nature Research<\/em> journal. The study received financial support from the Natural Sciences and Engineering Research Council of Canada<\/a> (NSERC), Mitacs<\/a>, the Fonds de recherche du Qu\u00e9bec – Nature et technologies<\/a> (FRQNT) and the Fonds de recherche du Qu\u00e9bec – Sant\u00e9<\/a> (FRQS), among others.<\/p>\n","protected":false},"excerpt":{"rendered":"

A research team from the INRS has improved the protective effect of a molecule against ischemic stroke, which is caused by an interruption of blood flow to the brain.<\/p>\n","protected":false},"author":392,"featured_media":47884,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[688],"tags":[],"sectors":[679,731],"class_list":["post-45198","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-innover-a-linrs-en","sectors-sante-en","sectors-materiaux-en"],"acf":[],"yoast_head":"\nImproving stroke treatment with a modified therapeutic molecule | INRS<\/title>\n<meta name=\"description\" content=\"A research team from INRS has improved the protective effect of a molecule against ischemic stroke.\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Improving stroke treatment with a modified therapeutic molecule | INRS\" \/>\n<meta property=\"og:description\" content=\"A research team from INRS has improved the protective effect of a molecule against ischemic stroke.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dev.inrs.ca\/en\/news\/improving-stroke-treatment-with-a-modified-therapeutic-molecule\/\" \/>\n<meta property=\"og:site_name\" content=\"INRS\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/inrsciences\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-02-18T14:40:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-02-18T14:51:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/dev.inrs.ca\/wp-content\/uploads\/2021\/02\/web_120495406-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1320\" \/>\n\t<meta property=\"og:image:height\" content=\"1103\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"audrey-maude vezina\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@inrsciences\" \/>\n<meta name=\"twitter:site\" content=\"@inrsciences\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"audrey-maude vezina\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/dev.inrs.ca\/en\/news\/improving-stroke-treatment-with-a-modified-therapeutic-molecule\/\",\"url\":\"https:\/\/dev.inrs.ca\/en\/news\/improving-stroke-treatment-with-a-modified-therapeutic-molecule\/\",\"name\":\"Improving stroke treatment with a modified therapeutic molecule | INRS\",\"isPartOf\":{\"@id\":\"https:\/\/dev.inrs.ca\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/dev.inrs.ca\/en\/news\/improving-stroke-treatment-with-a-modified-therapeutic-molecule\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/dev.inrs.ca\/en\/news\/improving-stroke-treatment-with-a-modified-therapeutic-molecule\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/dev.inrs.ca\/wp-content\/uploads\/2021\/02\/web_120495406-1.png\",\"datePublished\":\"2021-02-18T14:40:17+00:00\",\"dateModified\":\"2021-02-18T14:51:00+00:00\",\"author\":{\"@id\":\"https:\/\/dev.inrs.ca\/en\/#\/schema\/person\/bc47a91605ef9b28bcc2ae1940f3a0df\"},\"description\":\"A research team from INRS has improved the protective effect of a molecule against ischemic stroke.\",\"breadcrumb\":{\"@id\":\"https:\/\/dev.inrs.ca\/en\/news\/improving-stroke-treatment-with-a-modified-therapeutic-molecule\/#breadcrumb\"},\"inLanguage\":\"en-CA\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/dev.inrs.ca\/en\/news\/improving-stroke-treatment-with-a-modified-therapeutic-molecule\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-CA\",\"@id\":\"https:\/\/dev.inrs.ca\/en\/news\/improving-stroke-treatment-with-a-modified-therapeutic-molecule\/#primaryimage\",\"url\":\"https:\/\/dev.inrs.ca\/wp-content\/uploads\/2021\/02\/web_120495406-1.png\",\"contentUrl\":\"https:\/\/dev.inrs.ca\/wp-content\/uploads\/2021\/02\/web_120495406-1.png\",\"width\":1320,\"height\":1103},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/dev.inrs.ca\/en\/news\/improving-stroke-treatment-with-a-modified-therapeutic-molecule\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"INRS\",\"item\":\"https:\/\/dev.inrs.ca\/linrs\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Newsroom\",\"item\":\"https:\/\/dev.inrs.ca\/linrs\/salle-de-nouvelles\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"News\",\"item\":\"https:\/\/dev.inrs.ca\/linrs\/salle-de-nouvelles\/actualites\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Improving stroke treatment with a modified therapeutic molecule\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/dev.inrs.ca\/en\/#website\",\"url\":\"https:\/\/dev.inrs.ca\/en\/\",\"name\":\"INRS\",\"description\":\"Institut national de la recherche scientifique\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/dev.inrs.ca\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-CA\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/dev.inrs.ca\/en\/#\/schema\/person\/bc47a91605ef9b28bcc2ae1940f3a0df\",\"name\":\"audrey-maude vezina\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-CA\",\"@id\":\"https:\/\/dev.inrs.ca\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/265b1b816423e04ab7e508dd758fb951?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/265b1b816423e04ab7e508dd758fb951?s=96&d=mm&r=g\",\"caption\":\"audrey-maude vezina\"},\"url\":\"https:\/\/dev.inrs.ca\/en\/author\/audrey-maude-vezinainrs-ca\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Improving stroke treatment with a modified therapeutic molecule | INRS","description":"A research team from INRS has improved the protective effect of a molecule against ischemic stroke.","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"en_US","og_type":"article","og_title":"Improving stroke treatment with a modified therapeutic molecule | INRS","og_description":"A research team from INRS has improved the protective effect of a molecule against ischemic stroke.","og_url":"https:\/\/dev.inrs.ca\/en\/news\/improving-stroke-treatment-with-a-modified-therapeutic-molecule\/","og_site_name":"INRS","article_publisher":"https:\/\/www.facebook.com\/inrsciences\/","article_published_time":"2021-02-18T14:40:17+00:00","article_modified_time":"2021-02-18T14:51:00+00:00","og_image":[{"width":1320,"height":1103,"url":"https:\/\/dev.inrs.ca\/wp-content\/uploads\/2021\/02\/web_120495406-1.png","type":"image\/png"}],"author":"audrey-maude vezina","twitter_card":"summary_large_image","twitter_creator":"@inrsciences","twitter_site":"@inrsciences","twitter_misc":{"Written by":"audrey-maude vezina","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/dev.inrs.ca\/en\/news\/improving-stroke-treatment-with-a-modified-therapeutic-molecule\/","url":"https:\/\/dev.inrs.ca\/en\/news\/improving-stroke-treatment-with-a-modified-therapeutic-molecule\/","name":"Improving stroke treatment with a modified therapeutic molecule | INRS","isPartOf":{"@id":"https:\/\/dev.inrs.ca\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/dev.inrs.ca\/en\/news\/improving-stroke-treatment-with-a-modified-therapeutic-molecule\/#primaryimage"},"image":{"@id":"https:\/\/dev.inrs.ca\/en\/news\/improving-stroke-treatment-with-a-modified-therapeutic-molecule\/#primaryimage"},"thumbnailUrl":"https:\/\/dev.inrs.ca\/wp-content\/uploads\/2021\/02\/web_120495406-1.png","datePublished":"2021-02-18T14:40:17+00:00","dateModified":"2021-02-18T14:51:00+00:00","author":{"@id":"https:\/\/dev.inrs.ca\/en\/#\/schema\/person\/bc47a91605ef9b28bcc2ae1940f3a0df"},"description":"A research team from INRS has improved the protective effect of a molecule against ischemic stroke.","breadcrumb":{"@id":"https:\/\/dev.inrs.ca\/en\/news\/improving-stroke-treatment-with-a-modified-therapeutic-molecule\/#breadcrumb"},"inLanguage":"en-CA","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dev.inrs.ca\/en\/news\/improving-stroke-treatment-with-a-modified-therapeutic-molecule\/"]}]},{"@type":"ImageObject","inLanguage":"en-CA","@id":"https:\/\/dev.inrs.ca\/en\/news\/improving-stroke-treatment-with-a-modified-therapeutic-molecule\/#primaryimage","url":"https:\/\/dev.inrs.ca\/wp-content\/uploads\/2021\/02\/web_120495406-1.png","contentUrl":"https:\/\/dev.inrs.ca\/wp-content\/uploads\/2021\/02\/web_120495406-1.png","width":1320,"height":1103},{"@type":"BreadcrumbList","@id":"https:\/\/dev.inrs.ca\/en\/news\/improving-stroke-treatment-with-a-modified-therapeutic-molecule\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"INRS","item":"https:\/\/dev.inrs.ca\/linrs\/"},{"@type":"ListItem","position":2,"name":"Newsroom","item":"https:\/\/dev.inrs.ca\/linrs\/salle-de-nouvelles\/"},{"@type":"ListItem","position":3,"name":"News","item":"https:\/\/dev.inrs.ca\/linrs\/salle-de-nouvelles\/actualites\/"},{"@type":"ListItem","position":4,"name":"Improving stroke treatment with a modified therapeutic molecule"}]},{"@type":"WebSite","@id":"https:\/\/dev.inrs.ca\/en\/#website","url":"https:\/\/dev.inrs.ca\/en\/","name":"INRS","description":"Institut national de la recherche scientifique","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.inrs.ca\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-CA"},{"@type":"Person","@id":"https:\/\/dev.inrs.ca\/en\/#\/schema\/person\/bc47a91605ef9b28bcc2ae1940f3a0df","name":"audrey-maude vezina","image":{"@type":"ImageObject","inLanguage":"en-CA","@id":"https:\/\/dev.inrs.ca\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/265b1b816423e04ab7e508dd758fb951?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/265b1b816423e04ab7e508dd758fb951?s=96&d=mm&r=g","caption":"audrey-maude vezina"},"url":"https:\/\/dev.inrs.ca\/en\/author\/audrey-maude-vezinainrs-ca\/"}]}},"_links":{"self":[{"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/posts\/45198","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/users\/392"}],"replies":[{"embeddable":true,"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/comments?post=45198"}],"version-history":[{"count":5,"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/posts\/45198\/revisions"}],"predecessor-version":[{"id":47899,"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/posts\/45198\/revisions\/47899"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/media\/47884"}],"wp:attachment":[{"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/media?parent=45198"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/categories?post=45198"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/tags?post=45198"},{"taxonomy":"sectors","embeddable":true,"href":"https:\/\/dev.inrs.ca\/en\/wp-json\/wp\/v2\/sectors?post=45198"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}